Dormandy JA, Charbonnel B, Eckland DJA et al (2005) Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial
Tirzepatide may suit adults with a BMI of 27 or higher who also face weight-related health problems
GLP-1 medications can reduce B12 absorption over time, and postpartum demands are already high
If dietary changes, a more powerful medication, or a modified exercise program do not get one off of their semaglutide plateau, they may have reached the limit of such drugs effectiveness
The other medication class, sodium-glucose cotransporter 2 inhibitors (SGLT2), lowers blood sugar levels by inducing the kidneys to remove excess glucose from the body through the urine
The medication mimics the action of natural GLP-1, a hormone released by the intestine in response to food intake